TREH
geneOn this page
Also known as TRETREAMGC129621
Summary
TREH (trehalase, HGNC:12266) is a protein-coding gene on chromosome 11q23.3, encoding Trehalase (O43280). Intestinal trehalase is probably involved in the hydrolysis of ingested trehalose.
This gene encodes an enzyme that hydrolyses trehalose, a disaccharide formed from two glucose molecules found mainly in fungi, plants, and insects. A partial duplication of this gene is located adjacent to this locus on chromosome 11. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 11181 — RefSeq curated summary.
At a glance
- Gene–disease (curated): diarrhea-vomiting due to trehalase deficiency (Supportive, GenCC)
- GWAS associations: 14
- Clinical variants (ClinVar): 102 total
- Phenotypes (HPO): 7
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_007180
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12266 |
| Approved symbol | TREH |
| Name | trehalase |
| Location | 11q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TRE, TREA, MGC129621 |
| Ensembl gene | ENSG00000118094 |
| Ensembl biotype | protein_coding |
| OMIM | 275360 |
| Entrez | 11181 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000264029, ENST00000397925, ENST00000527558, ENST00000531295, ENST00000613915, ENST00000854539
RefSeq mRNA: 2 — MANE Select: NM_007180
NM_001301065, NM_007180
CCDS: CCDS73401, CCDS73402
Canonical transcript exons
ENST00000264029 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000796071 | 118658680 | 118658733 |
| ENSE00000796072 | 118658905 | 118659017 |
| ENSE00000796073 | 118659370 | 118659481 |
| ENSE00000796074 | 118659747 | 118659964 |
| ENSE00000796076 | 118660866 | 118660915 |
| ENSE00000796077 | 118661160 | 118661282 |
| ENSE00001302378 | 118657316 | 118658441 |
| ENSE00003461195 | 118662881 | 118662968 |
| ENSE00003494992 | 118661890 | 118661990 |
| ENSE00003512150 | 118663339 | 118663439 |
| ENSE00003583528 | 118661637 | 118661729 |
| ENSE00003585564 | 118663052 | 118663196 |
| ENSE00003652439 | 118660539 | 118660733 |
| ENSE00003652500 | 118661393 | 118661509 |
| ENSE00003721071 | 118679539 | 118679650 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 93.26.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1609 / max 90.0600, expressed in 22 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122613 | 0.1327 | 19 |
| 122614 | 0.0282 | 9 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| jejunal mucosa | UBERON:0000399 | 93.26 | gold quality |
| duodenum | UBERON:0002114 | 92.11 | gold quality |
| small intestine | UBERON:0002108 | 81.94 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 81.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.27 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 75.44 | gold quality |
| ileal mucosa | UBERON:0000331 | 74.66 | silver quality |
| gall bladder | UBERON:0002110 | 73.13 | gold quality |
| right lobe of liver | UBERON:0001114 | 72.10 | gold quality |
| sural nerve | UBERON:0015488 | 71.77 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.42 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 69.94 | gold quality |
| jejunum | UBERON:0002115 | 69.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.95 | gold quality |
| kidney | UBERON:0002113 | 68.51 | gold quality |
| pancreatic ductal cell | CL:0002079 | 67.19 | silver quality |
| rectum | UBERON:0001052 | 67.14 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 66.11 | gold quality |
| metanephros cortex | UBERON:0010533 | 65.78 | gold quality |
| body of stomach | UBERON:0001161 | 65.76 | gold quality |
| transverse colon | UBERON:0001157 | 65.73 | gold quality |
| cortex of kidney | UBERON:0001225 | 65.59 | gold quality |
| body of pancreas | UBERON:0001150 | 64.16 | gold quality |
| liver | UBERON:0002107 | 63.95 | gold quality |
| intestine | UBERON:0000160 | 63.92 | gold quality |
| esophagus mucosa | UBERON:0002469 | 63.70 | gold quality |
| right atrium auricular region | UBERON:0006631 | 63.36 | gold quality |
| left uterine tube | UBERON:0001303 | 62.97 | gold quality |
| stomach | UBERON:0000945 | 62.49 | gold quality |
| cardiac atrium | UBERON:0002081 | 62.20 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.36 |
| E-MTAB-6075 | no | 96.82 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- These results suggest that TREH acts as a stress-response protein in the kidney rather than involved in utilization of exogenous trehalose. (PMID:19126402)
- we found three protective alleles for glioma patients, including the allele ‘‘T’’ of rs17748 in the TREH gene by recessive model (OR, 0.48; 95% CI, 0.23-1.01; P = 0.05) analysis (PMID:22369735)
- variants in TREH control trehalase activity, and although one of these variants is also reproducibly associated with T2D, it is likely that the effect of the SNP on risk of T2D occurs by a mechanism different than affecting trehalase activity. (PMID:23468175)
- results suggest a significant association between the RETL1, TREH, and PHLDB1 genes and GBM development in the Han Chinese population (PMID:26156397)
- In conclusion, we identified four novel loci (TGFA, PIK3R1, FGFR3 and TREH) and confirmed two loci known to be associated with cartilage thickness.The identified associations were not caused by rare exonic variants. This is the first report linking TGFA to human Osteoarthritis, which may serve as a new target for future therapies. (PMID:27701424)
- these results indicate that trehalose has anti-apoptotic effects through the suppression of oxidative stress-induced mitochondrial injury and ER stress which is dependent on the promotion of autophagic flux and the induction of selective autophagy (PMID:28981117)
Cross-species orthologs
10 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | treh | ENSDARG00000077911 |
| mus_musculus | Treh | ENSMUSG00000032098 |
| rattus_norvegicus | Treh | ENSRNOG00000052010 |
| drosophila_melanogaster | Treh | FBGN0003748 |
| drosophila_melanogaster | CG6262 | FBGN0034121 |
| caenorhabditis_elegans | tre-1 | WBGENE00006607 |
| caenorhabditis_elegans | WBGENE00006608 | |
| caenorhabditis_elegans | WBGENE00006609 | |
| caenorhabditis_elegans | WBGENE00006610 | |
| caenorhabditis_elegans | WBGENE00006611 |
Protein
Protein identifiers
Trehalase — O43280 (reviewed: O43280)
Alternative names: Alpha,alpha-trehalase, Alpha,alpha-trehalose glucohydrolase
All UniProt accessions (2): O43280, A0A087WTJ4
UniProt curated annotations — full annotation on UniProt →
Function. Intestinal trehalase is probably involved in the hydrolysis of ingested trehalose.
Subunit / interactions. Homodimer; disulfide-linked.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in kidney, liver and small intestine. Also more weakly expressed in pancreas.
Disease relevance. Trehalase deficiency (TREHD) [MIM:612119] An autosomal recessive condition characterized by the inability to digest trehalose, a disaccharide found in mushrooms, products containing baker’s yeast, and dried food. Individuals with trehalase deficiency suffer from abdominal pain, increased rectal flatulence, and diarrhea due to osmotic water flow into the colon. The gene represented in this entry is involved in disease pathogenesis.
Similarity. Belongs to the glycosyl hydrolase 37 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O43280-1 | 1 | yes |
| O43280-2 | 2 |
RefSeq proteins (2): NP_001287994, NP_009111* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001661 | Glyco_hydro_37 | Family |
| IPR008928 | 6-hairpin_glycosidase_sf | Homologous_superfamily |
| IPR012341 | 6hp_glycosidase-like_sf | Homologous_superfamily |
| IPR018232 | Glyco_hydro_37_CS | Conserved_site |
Pfam: PF01204
Enzyme classification (BRENDA):
- EC 3.2.1.28 — alpha,alpha-trehalase (BRENDA: 90 organisms, 95 substrates, 318 inhibitors, 114 Km, 29 kcat entries)
Substrate kinetics (BRENDA)
2 substrates with measured Km, best-characterized 2. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| ALPHA,ALPHA-TREHALOSE | 0.06–72.8 | 59 |
| TREHALOSE | 0.0109–55 | 50 |
Catalyzed reactions (Rhea), 1 shown:
- alpha,alpha-trehalose + H2O = alpha-D-glucose + beta-D-glucose (RHEA:32675)
UniProt features (24 total): binding site 7, sequence variant 5, glycosylation site 4, active site 2, signal peptide 1, chain 1, lipid moiety-binding region 1, splice variant 1, propeptide 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43280-F1 | 92.80 | 0.90 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 321 (proton donor/acceptor); 514 (proton donor/acceptor)
Ligand- & substrate-binding residues (7): 319; 529; 168; 175–176; 212; 221–223; 286–288
Post-translational modifications (1): 556
Glycosylation sites (4): 78, 239, 261, 369
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-189085 | Digestion of dietary carbohydrate |
MSigDB gene sets: 71 (showing top):
GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS, REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE, GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, HNF4_DR1_Q3, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, KEGG_STARCH_AND_SUCROSE_METABOLISM, GOBP_CARBOHYDRATE_CATABOLIC_PROCESS, GOCC_SIDE_OF_MEMBRANE, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS, YOSHIMURA_MAPK8_TARGETS_UP, MULLIGHAN_MLL_SIGNATURE_1_DN, HNF4ALPHA_Q6, GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS, CHEN_METABOLIC_SYNDROM_NETWORK
GO Biological Process (4): trehalose metabolic process (GO:0005991), trehalose catabolic process (GO:0005993), animal organ morphogenesis (GO:0009887), carbohydrate metabolic process (GO:0005975)
GO Molecular Function (3): alpha,alpha-trehalase activity (GO:0004555), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798)
GO Cellular Component (4): plasma membrane (GO:0005886), membrane (GO:0016020), extracellular exosome (GO:0070062), side of membrane (GO:0098552)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Digestion | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| membrane | 2 |
| cellular anatomical structure | 2 |
| disaccharide metabolic process | 1 |
| trehalose metabolic process | 1 |
| disaccharide catabolic process | 1 |
| anatomical structure morphogenesis | 1 |
| animal organ development | 1 |
| primary metabolic process | 1 |
| trehalase activity | 1 |
| catalytic activity | 1 |
| hydrolase activity | 1 |
| cell periphery | 1 |
| extracellular vesicle | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
1885 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TREH | MGAM | O43451 | 779 |
| TREH | SI | P14410 | 737 |
| TREH | MGAM2 | Q2M2H8 | 734 |
| TREH | PABPN1 | Q86U42 | 712 |
| TREH | PGM3 | O95394 | 592 |
| TREH | AMY2A | P04746 | 591 |
| TREH | UGP2 | Q16851 | 591 |
| TREH | PYGL | P06737 | 582 |
| TREH | PYGB | P11216 | 582 |
| TREH | PYGM | P11217 | 577 |
| TREH | PGGHG | Q32M88 | 575 |
| TREH | GPI | P06744 | 574 |
| TREH | AMY1B | P04745 | 565 |
| TREH | PHLDB1 | Q86UU1 | 563 |
| TREH | NTHL1 | P78549 | 560 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TREH | GPAA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): GPAA1 (Affinity Capture-MS), GPAA1 (Affinity Capture-MS)
ESM2 similar proteins: A0JMP0, A4IG42, A5PJN5, A6QLU7, A6QQ07, F1N2K1, O00462, O18835, O43280, O77695, O95479, O97524, P08236, P10253, P12265, P19813, P70699, P82450, Q3U4H6, Q4FAT7, Q4FZV0, Q5E985, Q5FVF9, Q5R5N6, Q5R7A9, Q5R8R3, Q5RFU0, Q5XHI4, Q641Z7, Q6P6V7, Q6P7A9, Q6QR59, Q6RHW4, Q76HN1, Q865R1, Q8BFW6, Q8BNE1, Q8BP56, Q8C0L6, Q8CFX1
Diamond homologs: A1AAC5, A1AH61, A7ZKW9, A7ZT60, A7ZZD1, A8A5X9, A8AFT6, A8J4S9, A9MLK7, A9MVX4, B0RNH1, B1IU96, B1J0B4, B1LHA4, B1LJ63, B1X7X4, B1XAN8, B2U4I7, B4SUI9, B4SWF1, B4T8D8, B4TXW7, B4TZ02, B5BI56, B5F4F0, B5F9H0, B5FKM4, B5FTN7, B5R2X4, B5R404, B5R904, B5RGS3, B5YVG5, B6I385, B6I9Q8, B7L603, B7LGV7, B7LSZ0, B7LXB1, B7M3D0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CDK1 | “up-regulates activity” | TREH | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
102 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 19 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2780 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:118658734:C:CC | acceptor_gain | 1.0000 |
| 11:118659833:C:CA | donor_gain | 1.0000 |
| 11:118661207:T:A | donor_gain | 1.0000 |
| 11:118661208:C:A | donor_gain | 1.0000 |
| 11:118661391:A:AC | donor_gain | 1.0000 |
| 11:118661392:C:CC | donor_gain | 1.0000 |
| 11:118663046:TCATA:T | donor_loss | 1.0000 |
| 11:118663047:CATAC:C | donor_loss | 1.0000 |
| 11:118663048:ATAC:A | donor_loss | 1.0000 |
| 11:118663049:TACCT:T | donor_loss | 1.0000 |
| 11:118663050:A:AT | donor_loss | 1.0000 |
| 11:118663051:C:CT | donor_loss | 1.0000 |
| 11:118663051:CCTGT:C | donor_gain | 1.0000 |
| 11:118663059:T:A | donor_gain | 1.0000 |
| 11:118663440:C:CC | acceptor_gain | 1.0000 |
| 11:118658730:CATA:C | acceptor_gain | 0.9900 |
| 11:118658732:TA:T | acceptor_gain | 0.9900 |
| 11:118659365:CCTA:C | donor_loss | 0.9900 |
| 11:118659366:CTACC:C | donor_loss | 0.9900 |
| 11:118659367:TA:T | donor_loss | 0.9900 |
| 11:118659368:A:G | donor_loss | 0.9900 |
| 11:118659369:CCT:C | donor_gain | 0.9900 |
| 11:118659748:T:TA | donor_gain | 0.9900 |
| 11:118660541:AG:A | donor_gain | 0.9900 |
| 11:118660665:A:T | acceptor_gain | 0.9900 |
| 11:118660667:C:CT | acceptor_gain | 0.9900 |
| 11:118660860:GCTCA:G | donor_loss | 0.9900 |
| 11:118660861:CTCAC:C | donor_loss | 0.9900 |
| 11:118660862:TCA:T | donor_loss | 0.9900 |
| 11:118660863:CACCT:C | donor_loss | 0.9900 |
AlphaMissense
3785 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:118658433:A:C | F536L | 0.998 |
| 11:118658433:A:T | F536L | 0.998 |
| 11:118658435:A:G | F536L | 0.998 |
| 11:118661907:A:C | F169L | 0.998 |
| 11:118661907:A:T | F169L | 0.998 |
| 11:118661909:A:G | F169L | 0.998 |
| 11:118661160:C:A | R286M | 0.997 |
| 11:118661160:C:G | R286T | 0.997 |
| 11:118658429:A:G | W538R | 0.995 |
| 11:118658429:A:T | W538R | 0.995 |
| 11:118660896:C:G | D293H | 0.995 |
| 11:118660915:C:A | R286S | 0.995 |
| 11:118660915:C:G | R286S | 0.995 |
| 11:118661483:C:G | R215P | 0.995 |
| 11:118659415:C:G | D463H | 0.994 |
| 11:118659418:A:G | W462R | 0.994 |
| 11:118659418:A:T | W462R | 0.994 |
| 11:118660675:G:C | F322L | 0.994 |
| 11:118660675:G:T | F322L | 0.994 |
| 11:118660677:A:G | F322L | 0.994 |
| 11:118660678:G:C | D321E | 0.994 |
| 11:118660678:G:T | D321E | 0.994 |
| 11:118660679:T:A | D321V | 0.994 |
| 11:118662901:A:G | W135R | 0.994 |
| 11:118662901:A:T | W135R | 0.994 |
| 11:118663373:C:A | K52N | 0.994 |
| 11:118663373:C:G | K52N | 0.994 |
| 11:118659416:C:A | W462C | 0.993 |
| 11:118659416:C:G | W462C | 0.993 |
| 11:118660680:C:G | D321H | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000269510 (11:118657612 T>C), RS1000600962 (11:118677182 G>A,C), RS1000654618 (11:118669204 G>A), RS1000714997 (11:118676799 C>A,T), RS1000943185 (11:118669725 C>G,T), RS1000975533 (11:118664099 A>C,G), RS1001429600 (11:118665807 A>C), RS1001501944 (11:118677277 C>T), RS1001859552 (11:118664538 C>T), RS1001931708 (11:118670560 T>G), RS1002059662 (11:118677684 C>G), RS1002435417 (11:118664759 G>C,T), RS1002745273 (11:118681420 G>A), RS1003136556 (11:118673592 G>A,T), RS1003190403 (11:118679711 C>T)
Disease associations
OMIM: gene MIM:275360 | disease phenotypes: MIM:612119
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| diarrhea-vomiting due to trehalase deficiency | Supportive | Autosomal dominant |
Mondo (1): diarrhea-vomiting due to trehalase deficiency (MONDO:0012803)
Orphanet (1): Trehalase deficiency (Orphanet:103909)
HPO phenotypes
7 total (7 of 7 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0002013 | Vomiting |
| HP:0002014 | Diarrhea |
| HP:0002024 | Malabsorption |
| HP:0002027 | Abdominal pain |
| HP:0003270 | Abdominal distention |
| HP:0012379 | Abnormal circulating enzyme concentration or activity |
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000817_136 | Height | 2.000000e-08 |
| GCST001670_2 | Vitiligo | 2.000000e-09 |
| GCST002388_19 | Serum metabolite levels | 3.000000e-30 |
| GCST003853_6 | Hip minimal joint space width | 2.000000e-07 |
| GCST005523_30 | Celiac disease | 2.000000e-11 |
| GCST005531_22 | Multiple sclerosis | 8.000000e-11 |
| GCST005534_4 | Systemic sclerosis | 1.000000e-07 |
| GCST005535_1 | Diffuse cutaneous systemic sclerosis | 3.000000e-06 |
| GCST005990_14 | Non-albumin protein levels | 2.000000e-08 |
| GCST006612_66 | LDL cholesterol | 8.000000e-11 |
| GCST008489_5 | Celiac disease | 2.000000e-08 |
| GCST009652_17 | Serum alkaline phosphatase levels | 1.000000e-09 |
| GCST010002_199 | Refractive error | 3.000000e-34 |
| GCST90011900_61 | Serum alkaline phosphatase levels | 7.000000e-39 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007873 | cartilage thickness measurement |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0004533 | alkaline phosphatase measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C562603 | Trehalase Deficiency (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3087 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 4,739 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL307429 | DUVOGLUSTAT | 2 | 4,739 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 2 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.75 | Ki | 180 | nM | SALBOSTATIN |
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Acetaminophen | decreases expression | 1 |
| Arbutin | decreases expression | 1 |
| Hydrocortisone | decreases activity | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
ChEMBL screening assays
4 unique, capped per target: 4 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL812720 | Binding | Evaluated for the inhibition of trehalase from porcine kidneys | Total synthesis of trehalase inhibitor salbostatin — Bioorg Med Chem Lett |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: diarrhea-vomiting due to trehalase deficiency
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): celiac disease, diarrhea-vomiting due to trehalase deficiency, diffuse scleroderma, multiple sclerosis, systemic sclerosis, vitiligo